50 related articles for article (PubMed ID: 17920583)
1. Modulation of cardiac activity by tachykinins in the rat substantia nigra.
Lessard A; Couture R
Br J Pharmacol; 2001 Dec; 134(8):1749-59. PubMed ID: 11739252
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of tachykinin NK-1 and NK-3 receptor binding sites in the spinal cord of spontaneously hypertensive rat: impact on the autonomic control of blood pressure.
Cloutier F; Ongali B; Deschamps K; Brouillette J; Neugebauer W; Couture R
Br J Pharmacol; 2006 May; 148(1):25-38. PubMed ID: 16491095
[TBL] [Abstract][Full Text] [Related]
3. Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study.
Lessard A; Campos MM; Neugebauer W; Couture R
Br J Pharmacol; 2003 Feb; 138(4):554-63. PubMed ID: 12598409
[TBL] [Abstract][Full Text] [Related]
4. Activation of neurokinin 3 receptors in the median preoptic nucleus decreases core temperature in the rat.
Dacks PA; Krajewski SJ; Rance NE
Endocrinology; 2011 Dec; 152(12):4894-905. PubMed ID: 22028440
[TBL] [Abstract][Full Text] [Related]
5. Rapid elucidation of agonist-driven regulation of the neurokinin 1 receptor using a GPCR phosphorylation immunoassay.
Blum NK; Schaffner A; Drube J; Nagel F; Reinscheid RK; Hoffmann C; Schulz S
Eur J Pharmacol; 2024 Jun; 973():176587. PubMed ID: 38642667
[TBL] [Abstract][Full Text] [Related]
6. Identification of an Intravenous Injectable NK1 Receptor Antagonist for Use in Traumatic Brain Injury.
Vink R; Nimmo A
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542509
[TBL] [Abstract][Full Text] [Related]
7. Neurokinin B Administration Induces Dose Dependent Proliferation of Seminal Vesicles in Adult Rats.
Ramzan MH; Shah M; Ramzan F
Curr Protein Pept Sci; 2024 Jan; ():. PubMed ID: 38243941
[TBL] [Abstract][Full Text] [Related]
8. Ionic signalling mechanisms involved in neurokinin-3 receptor-mediated augmentation of fear-potentiated startle response in the basolateral amygdala.
Boyle CA; Hu B; Quaintance KL; Mastrud MR; Lei S
J Physiol; 2022 Oct; 600(19):4325-4345. PubMed ID: 36030507
[TBL] [Abstract][Full Text] [Related]
9. Maropitant citrate for treatment of ulcerative dermatitis in mice with a C57BL/6 background.
Williams-Fritze MJ; Carlson Scholz JA; Zeiss C; Deng Y; Wilson SR; Franklin R; Smith PC
J Am Assoc Lab Anim Sci; 2011 Mar; 50(2):221-6. PubMed ID: 21439216
[TBL] [Abstract][Full Text] [Related]
10. Receptors and antagonists for substance P and related peptides.
Regoli D; Boudon A; Fauchére JL
Pharmacol Rev; 1994 Dec; 46(4):551-99. PubMed ID: 7534932
[No Abstract] [Full Text] [Related]
11. Neurokinin receptors subserving bronchoconstriction.
Ellis JL
Can J Physiol Pharmacol; 1995 Jul; 73(7):923-6. PubMed ID: 8846431
[TBL] [Abstract][Full Text] [Related]
12. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
13. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
Nordquist RE; Durkin S; Jacquet A; Spooren W
Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of MEN 11467: a potent new selective and orally- effective peptidomimetic tachykinin NK(1) receptor antagonist.
Cirillo R; Astolfi M; Conte B; Lopez G; Parlani M; Sacco G; Terracciano R; Fincham CI; Sisto A; Evangelista S; Maggi CA; Manzini S
Neuropeptides; 2001; 35(3-4):137-47. PubMed ID: 11884203
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
